Cme Group Stock Today

CME Stock  USD 238.00  0.67  0.28%   

Performance

16 of 100

 
Weak
 
Strong
Solid

Odds Of Distress

Less than 5

 
High
 
Low
Very Low
CME is trading at 238.00 as of the 30th of November 2024, a 0.28 percent increase since the beginning of the trading day. The stock's lowest day price was 235.9. CME has under 5 % chance of experiencing financial distress over the next 2 years and had a solid performance during the last 90 days. Note, on September 2, 2024, Representative John James of US Congress acquired under $15k worth of CME Group's common stock.
Business Domain
Financial Services
IPO Date
6th of December 2002
Classification
Financials
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. The company has 360.36 M outstanding shares of which 3.81 M shares are currently shorted by investors with about 2.37 days to cover. More on CME Group

Moving together with CME Stock

  0.78VALU Value LinePairCorr
  0.72FDS FactSet Research SystemsPairCorr

CME Stock Highlights

ESG Sustainability
Environmental
Governance
Social
ChairmanTerrence Duffy
Thematic Ideas
(View all Themes)
Old Names[CENTRAL EURO MEDI-A (CME.SG), Central European Media Enterprises Ltd, AM METALS UCITS ETF, AM METALS UCITS ETF]
Business ConcentrationFinancial Exchanges & Data, Financial Data & Stock Exchanges, Financial Services, SP 500 Index, NASDAQ Composite, NASDAQ Financial 100, NASDAQ Composite Total, Macroaxis Picks, Blockchain, Financials, Capital Markets, Financial Data & Stock Exchanges, Financial Services (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.04090.043
Notably Down
Slightly volatile
Gross Profit Margin0.920.8139
Moderately Up
Pretty Stable
Total Current Liabilities98.1 B93.4 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total7.4 B9.6 B
Significantly Down
Slightly volatile
Total Assets136.2 B129.7 B
Sufficiently Up
Slightly volatile
Total Current Assets99.6 B94.9 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities3.6 B3.5 B
Sufficiently Up
Slightly volatile
Debt Levels
CME can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CME's financial leverage. It provides some insight into what part of CME's total assets is financed by creditors.
Liquidity
CME Group has 3.88 B in debt with debt to equity (D/E) ratio of 0.12, which may show that the company is not taking advantage of profits from borrowing. CME Group has a current ratio of 1.0, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Note however, debt could still be an excellent tool for CME to invest in growth at high rates of return.

Free Cash Flow

3.55 Billion
CME Group (CME) is traded on NASDAQ Exchange in USA. It is located in 20 South Wacker Drive, Chicago, IL, United States, 60606 and employs 3,565 people. CME is listed under Financial Exchanges & Data category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 85.77 B. CME Group runs under Capital Markets sector within Financials industry. The entity has 360.36 M outstanding shares of which 3.81 M shares are currently shorted by investors with about 2.37 days to cover. CME Group has about 2.22 B in cash with 3.45 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19.
Check CME Probability Of Bankruptcy
Ownership Allocation
CME holds a total of 360.36 Million outstanding shares. The majority of CME Group outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CME Group to benefit from reduced commissions. Thereupon, institutional investors are subject to a different set of regulations than regular investors in CME. Please pay attention to any change in the institutional holdings of CME Group as this could imply that something significant has changed or is about to change at the company. Please note that on September 2, 2024, Representative John James of US Congress acquired under $15k worth of CME Group's common stock.
Check CME Ownership Details

CME Stock Institutional Holders

InstituionRecorded OnShares
Fidelity International Ltd2024-06-30
3.9 M
Northern Trust Corp2024-09-30
3.5 M
Vontobel Holding Ltd.2024-06-30
3.5 M
Fiera Capital Corporation2024-06-30
3.3 M
Guardcap Asset Management Limited2024-09-30
3.3 M
Royal Bank Of Canada2024-06-30
3.2 M
Mitsubishi Ufj Asset Management Co.,ltd2024-09-30
M
Raymond James & Associates2024-09-30
2.9 M
Legal & General Group Plc2024-06-30
2.8 M
Vanguard Group Inc2024-09-30
33.9 M
Blackrock Inc2024-06-30
25.7 M
View CME Diagnostics

CME Historical Income Statement

At present, CME's Selling And Marketing Expenses is projected to increase significantly based on the last few years of reporting. The current year's EBIT is expected to grow to about 3.6 B, whereas Total Revenue is forecasted to decline to about 3 B. View More Fundamentals

CME Stock Against Markets

CME Corporate Directors

Hilda PiellChief Human Resource Officer, Senior Managing DirectorProfile
Jack TobinChief Accounting Officer, Managing DirectorProfile
Derek SammannSenior Managing Director - Financial Products and ServicesProfile
Julie WinklerSenior Managing Director - Research and Product DevelopmentProfile
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Financial Exchanges & Data space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.214
Dividend Share
4.55
Earnings Share
9.52
Revenue Per Share
16.795
Quarterly Revenue Growth
0.185
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.